| Literature DB >> 28970964 |
Jun Xiao1, Xiaowei Li1, Juan Liu1, Xiu Fan1, Huifen Lei1, Cuiying Li1.
Abstract
BACKGROUND: Tibetans have lived at high altitudes for thousands of years, and they have unique physiological traits that enable them to tolerate this hypoxic environment. However, the genetic basis of these traits is still unknown. As a sensitive and highly efficient technique, RT-qPCR is widely used in gene expression analyses to provide insight into the molecular mechanisms underlying environmental changes. However, the quantitative analysis of gene expression in blood is limited by a shortage of stable reference genes for the normalization of mRNA levels. Thus, systematic approaches were used to identify potential reference genes.Entities:
Keywords: Expression stability; Gene expression; Hypoxia; Plateau; Reference gene
Year: 2017 PMID: 28970964 PMCID: PMC5622608 DOI: 10.7717/peerj.3726
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Primer sequence information for RT-qPCR amplification used in this study.
| Symbol | Gene name | Accession number | Forward primer sequence [5′–3′] | Position in cDNA | Reverse primer sequence [5′–3′] | Position in cDNA | Production size |
|---|---|---|---|---|---|---|---|
| GAPDH | Glyceraldehyde |
| TCCAAAATCAAGTGGGGCGA | 4th exon | TGATGACCCTTTTGGCTCCC | 5th exon | 115 bp |
| ACTB | β-actin |
| CTTCCAGCCTTCCTTCCTGG | 4th exon | CTGTGTTGGCGTACAGGTCT | 5th exon | 110 bp |
| 18s RNA | 18s RNA |
| GGAGCCTGCGGCTTAATTTG | CCACCCACGGAATCGAGAAA | 100 bp | ||
| β2-MG | β2-microglobulin |
| TGGGTTTCATCCATCCGACA | 2th exon | TCAGTGGGGGTGAATTCAGTG | 2 exon | 138 bp |
| PPIA | Peptidylprolylisomerase A |
| GACTGAGTGGTTGGATGGCA | 4th exon | TCGAGTTGTCCACAGTCAGC | 5th exon | 141 bp |
| RPL13A | Ribosomal protein L13 |
| AAAAGCGGATGGTGGTTCCT | 6th exon | GCTGTCACTGCCTGGTACTT | 7th exon | 118 bp |
| TBP | TATA-Box binding protein |
| CAGCTTCGGAGAGTTCTGGG | 3th exon | TATATTCGGCGTTTCGGGCA | 4th exon | 117 bp |
| SDHA | Succinate dehydrogenase complex, subunit A |
| AAACTCGCTCTTGGACCTGG | 10th exon | TCTTCCCCAGCGTTTGGTTT | 11th exon | 111 bp |
RT-qPCR analysis for determination of the amplification efficiency.
| Gene | Slope | ||
|---|---|---|---|
| GAPDH | −3.162 | 107.1 | 0.999 |
| ACTB | −3.432 | 95.6 | 0.997 |
| 18s RNA | −3.422 | 96.0 | 0.998 |
| β2-MG | −3.302 | 100.8 | 0.998 |
| PPIA | −3.014 | 114.7 | 0.990 |
| RPL13A | −3.254 | 102.9 | 0.999 |
| TBP | −3.227 | 104.1 | 0.997 |
| SDHA | −3.199 | 105.4 | 0.997 |
Notes.
efficiency
correlation coefficient
Figure 1Specificity of RT-qPCR amplicons.
Dissociation curves with single peaks were generated from all amplicons and showed no dimer formation for each reference gene.
Descriptive statistics and normality evaluation of the reference genes Cq values before and after entering plateau.
| Gene | Mean | SD | Min | Max | SW-test | |
|---|---|---|---|---|---|---|
| Before plateau | GAPDH | 18.41 | 0.09 | 18.31 | 18.52 | 0.248 |
| ACTB | 13.40 | 0.13 | 13.25 | 13.63 | 0.601 | |
| 18s RNA | 15.84 | 0.56 | 14.79 | 16.63 | 0.989 | |
| β2-MG | 15.86 | 0.30 | 15.46 | 16.25 | 0.326 | |
| PPIA | 16.82 | 0.18 | 16.66 | 17.09 | 0.095 | |
| RPL13A | 13.88 | 0.10 | 13.71 | 14.00 | 0.620 | |
| TBP | 21.34 | 0.26 | 20.96 | 21.75 | 0.996 | |
| SDHA | 19.79 | 0.26 | 19.41 | 20.17 | 0.963 | |
| After plateau | GAPDH | 18.01 | 0.28 | 17.68 | 18.40 | 0.664 |
| ACTB | 14.35 | 0.43 | 13.84 | 14.89 | 0.526 | |
| 18s RNA | 15.79 | 0.29 | 15.32 | 16.10 | 0.616 | |
| β2-MG | 16.43 | 0.45 | 15.71 | 16.90 | 0.661 | |
| PPIA | 16.96 | 0.30 | 16.38 | 17.26 | 0.089 | |
| RPL13A | 13.60 | 0.15 | 13.39 | 13.77 | 0.486 | |
| TBP | 21.78 | 0.73 | 20.50 | 22.60 | 0.530 | |
| SDHA | 20.11 | 0.32 | 19.67 | 20.57 | 0.987 |
Notes.
standard deviation
minimum Cq value
maximum Cq value
p-value of the Shapiro–Wilk test
Figure 2Candidate reference gene Ct value distributions.
Boxplots of the Ct values from six volunteers from the plain (A) and the plateau (B) stages for each of the eight candidate reference genes.
Figure 3The geNorm selection analysis of candidate reference genes.
The average expression stability value (M) was calculated by geNorm for each gene on the plain (A), plateau (B) or both stages (C). Pairwise variation (V) between the normalization factors (Vn and Vn + 1) was used to determine the optimal number of reference genes for normalization on the plain (D), plateau (E) or both stages (F).
Calculation of candidate reference genes expression stability by the NormFinder.
| Ranking order | Gene | Stability value (Whole stages) | Gene | Stability value (Plain) | Gene | Stability value (plateau) |
|---|---|---|---|---|---|---|
| 1 | PPIA | 0.080 | GAPDH | 0.032 | PPIA | 0.076 |
| 2 | SDHA | 0.136 | RPL13A | 0.057 | SDHA | 0.166 |
| 3 | TBP | 0.205 | ACTB | 0.110 | ACTB | 0.176 |
| 4 | RPL13A | 0.227 | PPIA | 0.121 | RPL13A | 0.182 |
| 5 | 18s RNA | 0.229 | TBP | 0.167 | 18s RNA | 0.194 |
| 6 | β2-MG | 0.237 | SDHA | 0.210 | GAPDH | 0.237 |
| 7 | GAPDH | 0.265 | β2-MG | 0.264 | β2-MG | 0.244 |
| 8 | ACTB | 0.316 | 18s RNA | 0.434 | TBP | 0.369 |
Results from BestKeeper analysis.
| Gene | Whole stage | Plain | Plateau | |
|---|---|---|---|---|
| GAPDH | std dev [±CP] | 0.24 | 0.08 | 0.23 |
| CV [% CP] | 1.33 | 0.41 | 1.25 | |
| ACTB | std dev [±CP] | 0.48 | 0.11 | 0.35 |
| CV [% CP] | 3.45 | 0.82 | 2.45 | |
| 18s RNA | std dev [±CP] | 0.33 | 0.44 | 0.23 |
| CV [% CP] | 2.09 | 2.79 | 1.45 | |
| β2-MG | std dev [±CP] | 0.37 | 0.26 | 0.33 |
| CV [% CP] | 2.31 | 1.63 | 2.04 | |
| PPIA | std dev [±CP] | 0.21 | 0.16 | 0.19 |
| CV [% CP] | 1.24 | 0.93 | 1.15 | |
| RPL13A | std dev [±CP] | 0.15 | 0.09 | 0.12 |
| CV [% CP] | 1.10 | 0.62 | 0.89 | |
| TBP | std dev [±CP] | 0.43 | 0.22 | 0.53 |
| CV [% CP] | 1.98 | 1.01 | 2.42 | |
| SDHA | std dev [±CP] | 0.27 | 0.23 | 0.25 |
| CV [% CP] | 1.34 | 1.15 | 1.22 |
Stabilities of HKGs ranked by RefFinder.
| Ranking order | Whole stages | Plain | Plateau |
|---|---|---|---|
| 1 | PPIA | GAPDH | PPIA |
| 2 | RPL13A | RPL13A | RPL13A |
| 3 | SDHA | ACTB | 18sRNA |
| 4 | GAPDH | PPIA | SDHA |
| 5 | β2-MG | TBP | GAPDH |
| 6 | TBP | SDHA | ACTB |
| 7 | 18sRNA | β2-MG | β2-MG |
| 8 | ACTB | 18sRNA | TBP |